BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCT - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCT
X-ORIGINAL-URL:https://bioct.org
X-WR-CALDESC:Events for BioCT
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260618T120000
DTEND;TZID=America/New_York:20260618T133000
DTSTAMP:20260528T192159Z
CREATED:20260528T192159Z
LAST-MODIFIED:20260528T192159Z
UID:10003077-1781784000-1781789400@bioct.org
SUMMARY:Transitioning from Private to Public: Life Sciences IPO exit strategies
DESCRIPTION:A virtual discussion presented by Deloitte’s Capital Markets Transactions practice. \nPlease join Deloitte Life Sciences IPO leaders Tasia Blazevich and B.J. Spence as they lead us through key considerations and strategies. Tasia and B.J. will be joined by industry leaders who will share their perspectives on navigating the IPO process. \nYou will hear from industry leading professionals and experienced executives addressing topics such as: \n\nCapital markets update\nIPO strategy overview\nPerspectives from industry leading advisors\n\nSpeakers include: \n\nTasia Blazevich\, US Life Sciences IPO leader\, Deloitte\nB.J. Spence\, US Life Sciences IPO Leader\, Deloitte\nJohn Haynor\, Managing Director\, Solebury\nCarlos Ramirez\, Partner\, Cooley
URL:https://bioct.org/event/transitioning-from-private-to-public-life-sciences-ipo-exit-strategies/
LOCATION:VIRTUAL
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260618T120000
DTEND;TZID=America/New_York:20260618T133000
DTSTAMP:20260528T122500Z
CREATED:20260528T122358Z
LAST-MODIFIED:20260528T122500Z
UID:10003075-1781784000-1781789400@bioct.org
SUMMARY:Transitioning from Private to Public: Life Sciences IPO Exit Strategies - Hosted by Deloitte
DESCRIPTION:A virtual discussion presented by Deloitte’s Capital Markets Transactions practice. \nPlease join Deloitte Life Sciences IPO leaders Tasia Blazevich and B.J. Spence as they lead us through key considerations and strategies. Tasia and B.J. will be joined by industry leaders who will share their perspectives on navigating the IPO process. \nYou will hear from industry leading professionals and experienced executives addressing topics such as: \n\nCapital markets update\nIPO strategy overview\nPerspectives from industry leading advisors\n\nSpeakers include: \n\nTasia Blazevich\, US Life Sciences IPO leader\, Deloitte\nB.J. Spence\, US Life Sciences IPO Leader\, Deloitte\nJohn Haynor\, Managing Director\, Solebury\nCarlos Ramirez\, Partner\, Cooley
URL:https://bioct.org/event/transitioning-from-private-to-public-life-sciences-ipo-exit-strategies-hosted-by-deloitte/
LOCATION:VIRTUAL
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260611T113000
DTEND;TZID=America/New_York:20260611T183000
DTSTAMP:20260528T222846Z
CREATED:20260528T222846Z
LAST-MODIFIED:20260528T222846Z
UID:10003079-1781177400-1781202600@bioct.org
SUMMARY:IPO Workshop Co-Hosted by Deloitte and WilmerHale
DESCRIPTION:For many private companies\, regardless of industry sector\, going public is a transformative milestone. We’re here to help you understand next steps and think through when the timing may be right for your company to exit. \nJoin Deloitte and WilmerHale for an interactive workshop designed for C-suite executives\, and legal and finance leaders preparing for a public exit\, whether through an IPO or an alternative structure such as a reverse merger\, SPAC\, or direct listing. \nHear from seasoned market leaders\, executives\, and regulatory experts who have successfully navigated the IPO journey. \n\n\n\nWe’ll cover: \n\n\n\n\n\n\n\n\n\n\n\n\nCurrent market conditions and timing considerations\nBest practices for IPO readiness\nKey regulatory and governance requirements\nLife as a public company and lessons learned from recent transactions\n\n\n\n\n\n\n\n\n\nThe day begins with lunch and registration and concludes with a networking reception to connect with speakers and peers.
URL:https://bioct.org/event/ipo-workshop-co-hosted-by-deloitte-and-wilmerhale-2/
LOCATION:Deloitte\, 115 Federal Street\, Boston
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260611T113000
DTEND;TZID=America/New_York:20260611T183000
DTSTAMP:20260610T160944Z
CREATED:20260528T191623Z
LAST-MODIFIED:20260610T160944Z
UID:10003076-1781177400-1781202600@bioct.org
SUMMARY:IPO Workshop Co-Hosted by Deloitte and WilmerHale
DESCRIPTION:For many private companies\, regardless of industry sector\, going public is a transformative milestone. We’re here to help you understand next steps and think through when timing may be right for the company to exit. \nJoin Deloitte and WilmerHale on June 11 for an interactive workshop designed for C-suite executives\, and legal and finance leaders preparing for a public exit\, whether through an IPO or an alternative structure such as a reverse merger\, SPAC\, or direct listing. \nHear from seasoned market leaders\, executives\, and regulatory experts who have successfully navigated the IPO journey. \nWe’ll cover: \n\nCurrent market conditions and timing considerations\nBest practices for IPO readiness\nKey regulatory and governance requirements\nLife as a public company\, and lessons learned from recent transactions\n\nThe day begins with lunch and registration and concludes with a networking reception to connect with speakers and peers.
URL:https://bioct.org/event/ipo-workshop-co-hosted-by-deloitte-and-wilmerhale/
LOCATION:Deloitte Boston Office\, 115 Federal Street\, Winthrop Center Floors 12-15\, Boston\, 02110\, United States
END:VEVENT
END:VCALENDAR